The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Related Posts
Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg[...]
Appley M, Gray JR, Abdulrahim D, Bowden-Jones O. Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder. Addict Sci[...]
Lacasse Y, Maltais F, Casaburi R. The Potential of Chronic Hypoxia Biomarkers to Guide Home Oxygen Therapy Prescription in COPD. Respir Care. 2026 Jan;71(1):97-102. doi:[...]